Return
- 1M
- 3M
- 6M
- 1Y
- 3Y
- 5Y
This Fund:
Sensex:
BankFD:
Showing Funds Performance since Sep 07, 2020
Fund Overview
Min. investment
SIP ₹500 & Lump. ₹5000
AUM (Fund size)
₹224 Cr
Lock In Period
N/A
Expense Ratio
2.35
Benchmark
NIFTY Healthcare Total Return Index
Exit Load
If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.
Summary
Latest details for ITI Pharma and Healthcare Fund Growth include a ₹15.0687 NAV as of Feb 10,2026 and returns since inception of 64.02%. Minimum investments start at SIP ₹500. The ITI Pharma and Healthcare Fund Growth AUM is ₹224 Cr, with a lock-in of N/A years, expense ratio of 2.35%, and benchmark NIFTY Healthcare Total Return Index. Exit load is - If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50%.Exit Load after completion of 3 months - Nil.. In the growth review for 1M Month/Year, the fund recorded 0.00% returns, against a category average of 0.00% and a category best of 0.00%.
Calculate Returns
You would have got
Your Investment Amount
- 1
- 2
- 3
- 4
- 5
Growth Review
| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|
Portfolio Analysis
- Equity:
- Debt:
- Others
As on: 2025-12-31
View allocation % by
About Fund
ITI Pharma and Healthcare Fund Growth managed by ITI Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹224 Crore. The fund benchmarks its performance against the NIFTY Healthcare Total Return Index while maintaining an expense ratio of 2.35. Under the expert guidance of Dhimant Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Peer Comparison
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| This FundAditya Birla Sun Life ESG Integration Strategy Fund Growth | 0 | 616.29 CR | 2.47 |
| This FundAxis Innovation Fund Growth | 0 | 1196.33 CR | 2.26 |
| This FundITI Pharma and Healthcare Fund Growth | 0 | 223.8 CR | 2.35 |
| This FundICICI Prudential PSU Equity Fund Growth | 0 | 1902.83 CR | 2.09 |
| This FundNippon India Taiwan Equity Fund Growth | 3 | 427.47 CR | 2.43 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundAditya Birla Sun Life ESG Integration Strategy Fund Growth | 8.3577 | 56.5878 |
| This FundAxis Innovation Fund Growth | 4.387 | 58.7682 |
| This FundITI Pharma and Healthcare Fund Growth | -8.016 | 63.0907 |
| This FundICICI Prudential PSU Equity Fund Growth | 18.4989 | 118.3057 |
| This FundNippon India Taiwan Equity Fund Growth | 68.1005 | 166.8367 |
FAQs
ITI Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.
The expense ratio of ITI Pharma and Healthcare Fund Growth is 2.35. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.
ITI Pharma and Healthcare Fund Growth’s fund performance is as follows:
- 1 Month : %
- 6 Months : %
- 1 Year : %
- 3 Years : %
You can invest in ITI Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.
The fund size (AUM) of ITI Pharma and Healthcare Fund Growth is ₹224 crore. It changes based on market performance, inflows, and outflows.
You can track your investment in ITI Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500